Analysis of Tuberculosis Treatment and Outcome with Directly Observed Therapy Short Course
Abstract
A retrospective study analyzing tube rculosis (TB) treatment and outcome with Directly Observed Therapy Short Course (DOTS) in the first three years of its inception at the University of Nigeria Teaching Hospital (UNTH) (March 1995 to February 1998) was done. During the period, 1029 patients were seen. About two-thirds (67.9%) were young adults aged between 20 and 49 years. There was a female preponderance with a male to female ratio of 1:1.7. There were more urban (61.8%) than rural dwellers (36.8%). There was a sustained increase in the sputum conversion rate with the patients’ sputum smear negative at 2, 5 and 7 months being 97.90/0, 98.6% and 99.3% respectively. The cure rate was high at 87.9%. The default rate was also high at 29.30/0 with more than half occurring after 2 months of treatment. While 9.9% of the patients had retreatment, there was treatment failure in 0.8% and a low case fatality rate of 2.4%. DOTS therefore improved TB treatment outcome. There is need for improved enlightenment campaign / Health education. The absolute prerequisite for improving compliance and sustaining high cure rate is to ensure that the essential drugs will be continuously available free of charge to the patients.
Copyright © 2023 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
If you like this article, see others like it:
- Distribution of ABO, RH (Rhesus) Blood Grouping and Hepatitis B Among Blood Donors with National Blood Transfusion Service
- Impact of Health Education on the Awareness and Acceptability of Strategies for Preventing, Mother to Child Transmission of HIV among Antenatal Clients
- The Impact of Human Immunodeficiency Virus Syndromes on the Treatment Outcome of Tuberculosis Cases
- Prevalence and Management of Onchocerciasis in Oji River Local Government Area of Enugu State
- The Predictors of Adherence to Antiretroviral Therapy in HIV Positive Children